Acasti Pharma Inc.

Acasti Pharma Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
25.6 M
Public Float
9.49 M
Acasti Pharma Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.86
Market Cap
$110.91 M
Shares Outstanding
25.6 M
Public Float
9.49 M

Profile

Address
545 Promenade du Centropolis
Laval Québec H7T 0A3
Canada
Employees -
Website http://www.acastipharma.com
Updated 07/08/2019
Acasti Pharma, Inc. engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. It focuses on the research of prescription drugs using omega-3, fatty acids derived from krill oil. The company was founded by Henri Harland on February 1, 2002 and is headquartered in Laval, Canada.

Financials

View All
Created with Highcharts 5.0.14Acasti Pharma Inc.Net Income. Fiscal year is April-March. All values CAD Thousands.11 61111 6111 6541 6546 3166 31610 38110 38121 50421 50451 56651 566201420152016201720182019010k20k30k40k50k60k
Created with Highcharts 5.0.14Acasti Pharma Inc.Sales/Revenue. Fiscal year is April-March. All values CAD Thousands.50050027027037370000002014201520162017201820190100200300400500600

Janelle D'Alvise
President, Chief Executive Officer & Director
Roderick N. Carter
Executive Chairman